AI-generated summary
The authors report a double blind randomized controlled trial of 30 patients with trigeminal neuralgia, comparing low level laser therapy plus carbamazepine against sham laser plus carbamazepine over 9 sessions. Pain was lower at the end of treatment in the laser group, and both groups improved over time. The study is small and the abstract does not describe a long-term follow-up.
- Participants
- 30
- Who or what was studied
- Patients with trigeminal neuralgia (n=30), randomized into case and control groups of 15
- Limits stated in the abstract
- The abstract reports a small sample of 30 patients, with no long-term follow-up described and only a brief description of methods.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Control group, Low-level laser therapy, Visual analogue scale, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.